Should you buy soaring growth stock Versarien plc after 100% rise in a week?

Rapidly-doubling growth shares like Versarien plc (LON: VRS) don’t come along very often, so is it time to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Versarien (LSE: VRS) closed the day at 21.25p on 16 November, yet within a week they’d more than doubled to a high of 44.5p — at close on Thursday the price had dropped back to 39.1p, but that’s still an 84% gain.

So what is Versarien, and what’s going on?

The company, which describes itself as an “advanced materials engineering group,” produces something called Nanene — a particular type of ‘nano’ graphene. Graphene is claimed to be 200 times stronger than steel — and as it conducts electricity and heat, it has been touted as a replacement for copper wires and for use for circuitry on flexible surfaces.

The stuff sounds like it has great potential, and investor enthusiasm helped create a Versarien share price spike back in April — though that petered out over the subsequent few months.

Versarien is still in its cash-burn days — but the firm’s fundraising round in early November was very successful. So much so that it was more than twice oversubscribed, and was enlarged to raise a total of £2.9m.

Exciting progress

At recent rates of losses that might last around another year-and-a-half, but there’s been a big development that could potentially change all that — on 17 November, the company announced a collaboration with a “global consumer goods company,” and that’s the day the share price commenced its rapid ascent.

We’d already heard, in Versarien’s 3 November, trading update that it was “in advanced negotiations with two of the world’s largest consumer goods groups and anticipates receipt of the first purchase order imminently.” The latest update expanded that to say it “has now started collaborating with one of them to enable both groups to work together on research, development and testing of Versarien’s proprietary Nanene few layer graphene nano-platelets in polymer structures.”

As part of that, the as-yet-unidentified new partner has placed its first Nanene purchase order and will use it in polymer structures “primarily for packaging applications, for testing and evaluation, with a view to improving material strength, moisture control and recyclability.”

Negotiations are also in progress, we are told, with “a number of other multinational companies” with a view to further collaboration and commercialisation of the product.

But wait a mo…

This might make you want to rush over to your broker and place an order for Versarien shares — but before you do, you need to be aware of the risks.

Although the global graphene market is predicted to grow from a little over $20m at the end of 2016 to more than $600m by 2025 (and beyond that, who knows — very possibly into billions), the material is proving hard to commercialise and others firms have not been able to turn it into a big money-spinner yet.

And though Versarien’s new partnership deal (especially when coupled with other potential developments) does sound like a significant step forward, there are still many unanswered questions.

Will the commercialisation of the product be successful? How much of the funding for it will each partner contribute? How many ways and by what proportions will future profits be split? How long will it take before large-scale commercialisation becomes a reality? When will Versarien see its first profits? And what further funding (with accompanying dilution) will be needed before that time arrives?

Versarien could be very big, but it’s very risky.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

This FTSE 100 stock’s down 50% with a forward P/E of just 6.6! Is it a screaming buy for me?

This FTSE 100 homebuilder surged 40% during most of 2024 before crashing, creating what looks like a lucrative buying opportunity.…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Is Nvidia heading for the mother of all stock crashes in 2025?

After a seemingly unstoppable rise, is AI chipmaker Nvidia's stock going to suffer badly if the current AI boom cools…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Fancy a 13.9% dividend yield? Consider these dirt-cheap investment trusts!

These investment trusts are trading at whopping discounts to their net asset values (NAVs). Here's why they could prove to…

Read more »

Investing Articles

If the market shut down for 10 years, I’d be happy to hold these 2 FTSE 100 shares

Our writer reveals a pair of FTSE 100 shares that he reckons are well set up to deliver strong returns…

Read more »

Investing Articles

Surely, the Rolls-Royce share price can’t go any higher in 2025?

The Rolls-Royce share price was the best performer on the FTSE 100 in 2023 and so far in 2024. Dr…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Here’s how an investor could start buying shares with £100 in January

Our writer explains some of the things he thinks investors on a limited budget should consider before they start buying…

Read more »

Investing Articles

Forget FTSE 100 airlines! I think shares in this company offer better value to consider

Stephen Wright thinks value investors looking for shares to buy should include aircraft leasing company Aercap. But is now the…

Read more »

Investing Articles

Are Rolls-Royce shares undervalued heading into 2025?

As the new year approaches, Rolls-Royce shares are the top holding of a US fund recommended by Warren Buffett. But…

Read more »